BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND MLH1, COCA2, 4292, ENSG00000076242, hMLH1, FCC2, HNPCC2, P40692, MGC5172, HNPCC AND Diagnosis
59 results:

  • 1. Muir-Torre syndrome and recent updates on screening guidelines: The link between colorectal tumors and sebaceous adenomas in unusual locations.
    Shaker N; Shaker N; Abid A; Shah S; Shakra RA; Sangueza OP
    J Surg Oncol; 2023 Dec; 128(8):1380-1384. PubMed ID: 37706607
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Deficient mismatch repair is detected in large-to-giant congenital melanocytic naevi: providing new insight into aetiology and diagnosis.
    Wei B; Gu J; Gao B; Bao Y; Duan R; Li Q; Xie F
    Br J Dermatol; 2023 Jan; 188(1):64-74. PubMed ID: 36689509
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Liquid Biopsy as a Source of Nucleic Acid Biomarkers in the diagnosis and Management of Lynch Syndrome.
    Buglyó G; Styk J; Pös O; Csók Á; Repiska V; Soltész B; Szemes T; Nagy B
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457101
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Keratoacanthoma or cutaneous squamous cell carcinoma revealing a DNA mismatch repair default (Muir-Torre Syndrome).
    Miao Y; Kolb F; Tomasic G; Lupu J; Routier E; Robert C
    J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1():74-76. PubMed ID: 34855250
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pilomatricomas and café au lait macules as herald signs of constitutional mismatch repair deficiency (CMMRD) syndrome-A case report.
    Gupta A; George R; Aboobacker FN; ThamaraiSelvi B; Priscilla AJ
    Pediatr Dermatol; 2020 Nov; 37(6):1139-1141. PubMed ID: 32876971
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma.
    Abdel-Rahman MH; Sample KM; Pilarski R; Walsh T; Grosel T; Kinnamon D; Boru G; Massengill JB; Schoenfield L; Kelly B; Gordon D; Johansson P; DeBenedictis MJ; Singh A; Casadei S; Davidorf FH; White P; Stacey AW; Scarth J; Fewings E; Tischkowitz M; King MC; Hayward NK; Cebulla CM
    Ophthalmology; 2020 May; 127(5):668-678. PubMed ID: 32081490
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Update on the pathology, genetics and somatic landscape of sebaceous tumours.
    Ferreira I; Wiedemeyer K; Demetter P; Adams DJ; Arends MJ; Brenn T
    Histopathology; 2020 Apr; 76(5):640-649. PubMed ID: 31821583
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Ocular Adnexal Adenomatoid Sebaceous Gland Hyperplasia: A Clinical and Immunopathologic Analysis in Relation to the Muir-Torre Syndrome.
    Jakobiec FA; Cortes Barrantes P; Milman T; Lee NG; Fay A
    Ophthalmic Plast Reconstr Surg; 2020; 36(1):e6-e12. PubMed ID: 31593035
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Muir-Torre Syndrome: A Case Report in a Woman Without Personal cancer History.
    Torre K; Ricketts J; Dadras SS
    Am J Dermatopathol; 2019 Jan; 41(1):55-59. PubMed ID: 29933315
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Sebaceous adenocarcinomas of the major salivary glands: a clinicopathological analysis of 10 cases.
    Soares CD; Morais TML; Carlos R; Jorge J; de Almeida OP; de Carvalho MGF; Altemani AMM
    Histopathology; 2018 Oct; 73(4):585-592. PubMed ID: 29856905
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cutaneous Metastasis of Adenocarcinoma of the Ampulla of Vater.
    Fernandez-Flores A; Cassarino DS
    Am J Dermatopathol; 2018 Oct; 40(10):758-761. PubMed ID: 29672360
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Sebaceous tumours: more than skin deep.
    Jockenhöfer F; Schimming TT; Schaller J; Moege J; Livingstone E; Salva KA; Zimmer L; Schadendorf D; Rösch A
    Gut; 2018 Nov; 67(11):1957. PubMed ID: 29247065
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Risk of colorectal polyps and of malignancies in asymptomatic carriers of mutations in the main DNA mismatch repair genes.
    Ponz de Leon M; Pedroni M; Pezzi A; Sulce B; Roncucci L; Domati F; Rossi G; Reggiani Bonetti L
    Scand J Gastroenterol; 2018 Jan; 53(1):31-37. PubMed ID: 29025352
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Analysis of Sebaceous Neoplasms for DNA Mismatch Repair Proteins in Muir-Torre Syndrome.
    Pollinger TH; Kieliszak CR; Logemann N; Gratrix ML
    Skinmed; 2017; 15(4):259-264. PubMed ID: 28859734
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Single-Nucleotide Polymorphisms of the MSH2 and mlh1 Genes, Potential Molecular Markers for Susceptibility to the Development of Basal Cell Carcinoma in the Brazilian Population.
    da Silva Calixto P; Lopes OS; Dos Santos Maia M; Herrero SST; Longui CA; Melo CGF; de Carvalho Filho IR; Soares LF; de Medeiros AC; Delatorre P; Khayat AS; Burbano RR; Lima EM
    Pathol Oncol Res; 2018 Jul; 24(3):489-496. PubMed ID: 28667494
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cutaneous Sebaceous Lesions in a Patient With MUTYH-Associated Polyposis Mimicking Muir-Torre Syndrome.
    Kacerovska D; Drlik L; Slezakova L; Michal M; Stehlik J; Sedivcova M; Hadravsky L; Kazakov DV
    Am J Dermatopathol; 2016 Dec; 38(12):915-923. PubMed ID: 27870730
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Discordant Mismatch Repair Protein Immunoreactivity in Lynch Syndrome-Associated Neoplasms:  A Recommendation for Screening Synchronous/Metachronous Neoplasms.
    Roth RM; Haraldsdottir S; Hampel H; Arnold CA; Frankel WL
    Am J Clin Pathol; 2016 Jul; 146(1):50-6. PubMed ID: 27357288
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome.
    Ripperger T; Schlegelberger B
    Eur J Med Genet; 2016 Mar; 59(3):133-42. PubMed ID: 26743104
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Challenges for Urologists in the Care of Patients with Lynch Syndrome: Example of A Patient with Muir-Torre Syndrome, A Subtype of Lynch Syndrome].
    Löhmann C; Kächele V; Martinschek A; Sparwasser C
    Aktuelle Urol; 2016 Apr; 47(2):144-7. PubMed ID: 26509248
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Resolution of Benign and Malignant Sebaceous Neoplasms, in a Renal Transplant Patient Treated With Everolimus.
    Donati M; Paolino G; Muscardin L; Panetta C; Donati P
    Exp Clin Transplant; 2017 Feb; 15(1):100-102. PubMed ID: 25924010
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.